Table. 1.

Baseline patient characteristics in the eras before and after implementation of the MELD-based allocation system

Characteristics Overall (n=81) Before MELD (n=40) After MELD (n=41) P-value
Age (yr) 49 (43–55) 51 (45–55) 47 (42–55) 0.07
Male sex 53 (65) 28 (70) 25 (60) 0.48
Previous decompensation 38 (46) 21 (52) 17 (41) 0.37
Infection 20 (24) 6 (15) 14 (34) 0.07
GI bleeding 17 (21) 8 (20) 9 (22) 1.00
Varix 64 (79) 32 (80) 32 (78) 1.00
Hepatomegaly 37 (45) 17 (42) 20 (48) 0.65
Splenomegaly 66 (81) 33 (82) 33 (80) 1.00
Ascites 57 (70) 30 (75) 27 (65) 0.46
MELD score 0.82
<25 33 (41) 17 (42) 16 (39)
≥25 48 (59) 23 (57) 25 (61)
Liver biopsy 19 (23) 9 (22) 10 (24) 1.00
Corticosteroid use 22 (27) 11 (27) 11 (26) 1.00
Corticosteroid response 10/22 (45) 4/11 (36) 6/11 (54) 0.68
LT 37 (45) 10 (25) 27 (65) <0.001
LDLT 9 (11) 3 (7) 6 (14) 0.30
DDLT 28 (34) 7 (17) 21 (51) 0.001

Values are presented as median (interquartile range) or number (%).

MELD, Model for End-Stage Liver Disease; GI, gastrointestinal; LT, liver transplant; LDLT, live donor liver transplant; DDLT, deceased donor liver transplant.

Korean J Transplant 2021;35:24~32 https://doi.org/10.4285/kjt.20.0054
© Korean Journal of Transplantation